Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss affects women's self-esteem; treatments like minoxidil can help.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

The book provides comprehensive treatment strategies for female hair loss.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Certain foods and supplements can help treat skin diseases alongside medication.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Ozone therapy might improve cancer treatment and reduce its side effects.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hair loss requires customized treatments based on its various causes and types.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.